Beta Bionics, Inc. share price logo

Beta Bionics, Inc.

NASDAQ: BBNX

Small Cap

$19.92

+0.51

(+2.60%)

as on

Beta Bionics, Inc. Stock Performance

as on September 4, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $19.03
    $20.17
    downward going graph

    4.47%

    Downside

    1.26%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.80
    $32.71
    downward going graph

    55.82%

    Downside

    64.21%

    Upside

    downward going graph

Beta Bionics, Inc. share price movements today

Previous Close
$19.41
Open
$19.90
Volume
1.6M
Market Cap
$873.5M
Day's Low - High
$19.03 - $20.17
52 Week Low - High
$8.80 - $32.71

Beta Bionics, Inc. Historical Returns

1 Month Return
+ 36.72 %
3 Month Return
+ 43.41 %
1 Year Return
-0.9 %
3 Year Return
0 %
5 Year Return
0 %

Beta Bionics, Inc. Stock Fundamentals & Key Indicators

Check Beta Bionics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$873.5M

EPS (TTM)

-1.65

Dividend Yield

0.00%

PE Ratio (TTM)

-11.86

Industry PE ratio

-6.043658536585366

PEG Ratio

9.64773173391496

Return On Equity TTM

-26.30%

Beta Bionics, Inc. Stock Valuation

Track how Beta Bionics, Inc. P/E has moved over time to understand its valuation trends.

Beta Bionics, Inc. in the last 4 years

  • Overview

  • Trends

Lowest (-16.83x)

December 31, 2025

Today (-16.83x)

December 31, 2025

Industry (-6.04x)

December 31, 2025

Highest (-1.82x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -16.83x

Beta Bionics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beta Bionics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$873.5MNA-11.8658.31%NA
BUY$52.3B-25.84%51.677.98%NA
BUY$117.8B-30.85%24.1565.02%3.15%
BUY$124.2B14.3%32.6265.17%1.0999999999999999%
BUY$188.5B-15.63%35.1811.65%224.5%

Stock Returns calculator for Beta Bionics, Inc. Stock including INR - Dollar returns

The Beta Bionics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Beta Bionics, Inc. investment value today

Current value as on today

₹1,06,308

Returns

₹6,308

(+6.31%)

Returns from Beta Bionics, Inc. Stock

-₹896 (-0.90%)

Dollar Impact

₹7,204 (+7.2%)

Analyst Recommendation on Beta Bionics, Inc. Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.77777777777779% of analysts recommend a 'BUY' rating for Beta Bionics, Inc.. Average target price of $21.43

Indian Investors' Interest in Beta Bionics, Inc. Stock

Search interest for Beta Bionics, Inc. Stock has increased by 51% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:51% versus previous 30 day period

Beta Bionics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
8
16
20
17
23
27
32
27
32
Gross Profit
5
8
11
8
12
15
18
16
18
Operating Income
-8
-10
-13
-18
-19
-17
-16
-24
-25
EBITDA
-18
-9
-17
-28
-16
-13
-12
-21
-24
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
1
Income Before Tax
-18
-9
-18
-28
-16
-14
-13
-21
-23
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-18
-9
-18
-28
-16
-14
-13
-21
-23
Net Profit Margin
60.62%
53.36%
57.19%
50.86%
53.80%
55.48%
58.98%
59.50%
59.04%

Beta Bionics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
11
65
100
Gross Profit
0
6
35
55
Operating Income
-65
-35
-45
-71
EBITDA
-63
-42
-53
-70
Interest Expense
0
-
-
-
Depreciation
1
1
1
2
Income Before Tax
-64
-44
-54
-73
Income Tax Expense
-
-
-
-
Net Income
-64
-44
-54
-73
Net Profit Margin
100.00%
52.59%
55.11%
55.40%

Beta Bionics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-18
-9
-18
-28
-16
-14
-13
-21
-23
Operating Cash Flow
-6
-9
-14
-19
-13
-8
-8
-23
-14
Investing Cash Flow
-69
15
-29
-179
6
9
0
21
26
Financing Cash Flow
0
-1
56
211
0
2
1
0
1
Change in Cash
-75
4
12
12
-7
3
-6
-1
14

Beta Bionics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-64
-44
-54
-73
Operating Cash Flow
-60
-32
-48
-50
Investing Cash Flow
0
-69
-3
-162
Financing Cash Flow
56
101
55
214
Change in Cash
-4
-1
3
1

Mutual Funds that own Beta Bionics, Inc. Stock

Check out the Mutual Funds with significant holdings in Beta Bionics, Inc..

Funds
Holdings
Shares Held
MUTUAL FUND SERIES TRUST
13.12191%
5903507
VANGUARD INDEX FUNDS
3.746669%
1685615
Bruce Fund, Inc.
1.224058%
550700
Fidelity Salem Street Trust
0.940551%
423151
Fidelity Concord Street Trust
0.89999%
404903

Global Institutional Holdings in Beta Bionics, Inc.

Funds
Holdings
Vanguard
4.47%
iShares
3.76%
James E. Flynn
2.94%
Otello Stampacchia
2.93%
Richard Driehaus
2.13%

Insights on Beta Bionics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BBNX stock has moved up by 36.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 10.9% return, outperforming this stock by 11.8%

About Beta Bionics, Inc.

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is headquartered in Irvine, California.
OrganisationBeta Bionics, Inc.
Headquarters11 Hughes, Irvine, CA, United States, 92618
IndustryMedical Devices
CEOMr. Sean T. Saint PE
E-voting on sharesClick here to vote

Key Management of Beta Bionics, Inc.

Name

Title

Blake Beber

Head of Investor Relations

Dr. Steven Russell M.D., Ph.D.

Chief Medical Officer

Mr. Mark Hopman M.B.A., R.Ph.

Chief Commercial Officer

Mr. Sean T. Saint PE

President, CEO & Director

Mr. Stephen H. Feider

CFO, Treasurer & Secretary

Mr. Mike Mensinger

Chief Product Officer

Mr. David Henderson

Vice President of Operations

FAQs

What is Beta Bionics, Inc. share price today?

Beta Bionics, Inc. share price today is $19.92 as on at the close of the market. Beta Bionics, Inc. share today touched a day high of $20.17 and a low of $19.03.

What is the 52 week high and 52 week low for Beta Bionics, Inc. share?

Beta Bionics, Inc. share touched a 52 week high of $32.71 on and a 52 week low of $8.80 on . Beta Bionics, Inc. stock price today i.e. is closed at $19.92,which is 39.10% down from its 52 week high and 126.36% up from its 52 week low.

What is Beta Bionics, Inc.'s market capitalisation today?

Beta Bionics, Inc. market capitalisation is $0.00T as on .

How to invest in Beta Bionics, Inc. Stock (BBNX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Beta Bionics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Beta Bionics, Inc. Shares that will get you 0.0753 shares as per Beta Bionics, Inc. share price of $19.92 per share as on September 4, 2026 at 8:45 am IST.

What is the minimum amount required to buy Beta Bionics, Inc. Stock (BBNX) from India?

Indian investors can start investing in Beta Bionics, Inc. (BBNX) shares with as little as ₹94.475 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in Beta Bionics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Beta Bionics, Inc. share’s latest price of $19.92 as on September 4, 2026 at 8:45 am IST, you will get 0.5020 shares of Beta Bionics, Inc.. Learn more about fractional shares .